Thu.Dec 16, 2021

article thumbnail

Innovating to improve research integrity

Clarivate

How we’re expanding support for dealing with editorial expressions of concern and retractions. Research integrity is a key part of our mission at Clarivate to be a trusted, indispensable partner to innovators everywhere. Our research data, insights and analysis are used by the world’s top research institutions, by multiple governments and by national research agencies for global research assessment, which gives us a responsibility to monitor and act where we can to ensure the integrity of our da

article thumbnail

2022 Trends and Opportunities for Healthcare and Life Sciences Businesses and Investors

Nixon Gwilt Law

What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about? What do you wish more healthcare innovators knew about their business opportunities?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Women fighting COVID-19 with science: Spotlight on Alex Li

Clarivate

Throughout 2021, we brought you stories of women scientific researchers at Clarivate delivering invaluable contributions to innovation and customer success. Over the past two years, these women have done essential work in addressing COVID-19 and in helping to create a more equitable STEM field post-pandemic. Learn more. These colleagues have earned recognition and awards for excellence in their achievements in many different and specialist fields of scientific research.

article thumbnail

Pharma industry making record profits

World of DTC Marketing

(Axios) Second-quarter results are still pouring in, but so far, a vast majority of health care companies are reporting profits that many people assumed would not have been possible as the pandemic continued. Drug sales fell across many pharma companies but cutting administrative and research costs kept earnings at industry highs. Nine of the ten biggest profit margins recorded as July 31 belonged to drug companies.

Pharma 205
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud